RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Cambridge Investment Research Advisors, Inc.'s Holding History (CIK: 0001419186)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 73,958 Value ($000) $0 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 141,081 Value ($000) $1 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 127,249 Value ($000) $1 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 117,120 Value ($000) $1 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 87,984 Value ($000) $1 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 79,583 Value ($000) $1 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 76,968 Value ($000) $1 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 70,110 Value ($000) $1 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 63,996 Value ($000) $1 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 59,839 Value ($000) $0 Avg Close $9.98 Range $6.44 - $16.75